EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice

Naresh K Meena, Davide Randazzo, Nina Raben, Rosa Puertollano

JCI Insight · 22.08.2023 · 8 (16)

DOI: 10.1172/jci.insight.170199 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 22.08.2023. Verfasst von Naresh K Meena und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cell and Developmental Biology Center, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: alpha-Glucosidases, Glycogen Storage Disease Type II. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene therapy is under advanced clinical development for several lysosomal storage disorders. Pompe disease, a debilitating neuromuscular illness affecting infants, children, and adults with different severity, is caused by a deficiency of lysosomal glycogen-degrading enzyme acid α-glucosidase (GAA). Here, we demonstrated that adeno-associated virus–mediated (AAV-mediated) systemic gene transfer reversed glycogen storage in all key therapeutic targets — skeletal and cardiac muscles, the diaphragm, and the central nervous system — in both young and severely affected old Gaa -knockout mice. Furthermore, the therapy reversed secondary cellular abnormalities in skeletal muscle, such as those in autophagy and mTORC1/AMPK signaling. We used an AAV9 vector encoding a chimeric human GAA protein with enhanced uptake and secretion to facilitate efficient spread of the expressed protein among multiple target tissues. These results lay the groundwork for a future clinical development strategy in Pompe disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-GlucosidasesGlycogen Storage Disease Type IIChildMiceHumansAnimalsDependovirusGenetic VectorsMice, KnockoutGlycogen

Stichwörter der Autor:innen

AutophagyGene therapyMuscle BiologySkeletal muscle

Substanzen

alpha-GlucosidasesGlycogen

Autor:innen und Institutionen

  • Cell and Developmental Biology Center, National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, USA.
  • Light Imaging Section, Office of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland, USA.

Zitieren

APA

Meena, N. K., Randazzo, D., Raben, N., & Puertollano, R. (2023). AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice. JCI Insight, 8(16). https://doi.org/10.1172/jci.insight.170199

Vancouver

Meena NK, Randazzo D, Raben N, Puertollano R. AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice. JCI Insight. 2023;8(16). doi:10.1172/jci.insight.170199

BibTeX
@article{Meena2023,
  author = {Meena, Naresh K and Randazzo, Davide and Raben, Nina and Puertollano, Rosa},
  title = {AAV-mediated delivery of secreted acid α-glucosidase with enhanced uptake corrects neuromuscular pathology in Pompe mice},
  journal = {JCI Insight},
  year = {2023},
  volume = {8},
  number = {16},
  doi = {10.1172/jci.insight.170199}
}
Kostenlos starten →